Anixa Biosciences Announces Issuance of Canadian Patent for its CAR-T Cancer Therapy Technology

— Technology currently being evaluated for the treatment of ovarian cancer in Phase 1 clinical trial — SAN JOSE, Calif., July 11, 2023 /PRNewswire/ — Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of…

Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks